Prot# MAB-N007: A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight (VLBW) Neonates for the Prevention of Staphylococcal Sepsis

Project: Research project

Project Details

StatusFinished
Effective start/end date8/18/09 → 8/18/12

Funding

  • Biosynexus Incorporated (MAB-N007)